Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Related Articles


Article icon
Current Evidence and Future Directions of PCSK9 Inhibition

Jiaqian Xu, Michael D Shapiro,


Citation: US Cardiology Review 2021;15:e01.

HDL Cholesterol and Adverse Outcomes

Marc P Allard-Ratick, Pratik Sandesara, Arshed A Quyyumi,


Citation: US Cardiology Review 2019;13(1):49–53

Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease

Michael Megaly, Marwan Saad, Emmanouil S Brilakis,


Citation: US Cardiology Review 2019;13(1):16–20

Diabetes Drugs and Cardiovascular Event Reduction: A Paradigm Shift

Erik M Kelly, Donald E Cutlip,

Citation: US Cardiology Review 2018;12(1):46–50.